129 related articles for article (PubMed ID: 10525938)
21. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
Franchi A; Gallo O; Boddi V; Santucci M
Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
[TBL] [Abstract][Full Text] [Related]
22. [Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].
Starska K; Kulig A; Łukomski M
Pol Merkur Lekarski; 2003 Jul; 15(85):55-60. PubMed ID: 14593961
[TBL] [Abstract][Full Text] [Related]
23. p53 expression and cell proliferation as prognostic factors in laryngeal squamous cell carcinoma.
Hirvikoski P; Kumpulainen E; Virtaniemi J; Johansson R; Haapasalo H; Marin S; Halonen P; Helin H; Raitiola H; Pukander J; Kellokumpu-Lehtinen P; Kosma VM
J Clin Oncol; 1997 Sep; 15(9):3111-20. PubMed ID: 9294474
[TBL] [Abstract][Full Text] [Related]
24. Alteration of p53 gene structure and function in laryngeal squamous cell cancer.
Golusinski W; Olofsson J; Szmeja Z; Szyfter K; Szyfter W; Biczysko W; Hemminki K
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S133-7. PubMed ID: 9065648
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szkudlarek T; Jeleń-Krzeszewska J
Oral Oncol; 1999 Mar; 35(2):180-6. PubMed ID: 10435153
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
[TBL] [Abstract][Full Text] [Related]
28. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
29. [Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity].
Welkoborsky HJ; Gluckman JL; Jacob R; Bernauer H; Mann W
Laryngorhinootologie; 1999 Mar; 78(3):131-8. PubMed ID: 10226980
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Murao S; Kunachak S; Maeda S
Cancer Lett; 2000 Nov; 160(2):199-208. PubMed ID: 11053650
[TBL] [Abstract][Full Text] [Related]
32. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
[TBL] [Abstract][Full Text] [Related]
33. [Precancerous states of the larynx: analysis of mono- and polyclonality of the cells with high proliferative index (p53, PCNA)].
Gabriel A; Namysłowski G; Drozdzowska B; Morawski K; Steplewska-Mazur K; Gwóźdź M
Otolaryngol Pol; 2000; 54 Suppl 31():178-81. PubMed ID: 10974878
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
[TBL] [Abstract][Full Text] [Related]
35. Is p53 an independent prognostic factor in patients with laryngeal carcinoma?
Narayana A; Vaughan AT; Gunaratne S; Kathuria S; Walter SA; Reddy SP
Cancer; 1998 Jan; 82(2):286-91. PubMed ID: 9445184
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between tumor cell proliferating activity and biological behavior, prognosis in laryngeal carcinoma].
Zhou G; Liang C; Lin D; Zhang X; Wen D; Liu Y
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):178-81. PubMed ID: 10684010
[TBL] [Abstract][Full Text] [Related]
37. Changes in expression of p53, proliferating cell nuclear antigen and bcl-2 in recurrent laryngeal cancer after radiotherapy.
Lee BJ; Wang SG; Roh HJ; Goh EK; Chon KM; Park DY
J Laryngol Otol; 2006 Jul; 120(7):579-82. PubMed ID: 16672091
[TBL] [Abstract][Full Text] [Related]
38. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
[TBL] [Abstract][Full Text] [Related]
39. Tumor front grading in prediction of survival and lymph node metastases in patients with laryngeal carcinoma.
Starska K; Kulig A; Lukomski M
Adv Med Sci; 2006; 51():200-4. PubMed ID: 17357309
[TBL] [Abstract][Full Text] [Related]
40. [Immunohistochemical markers of cell proliferation in laryngeal carcinoma].
Urpegui García AM; Morandeira García MJ; Soria Navarro J; Rivas Rodríguez P; Valencia Julve J; Fernández Larripa S; Vallés Varela H
Acta Otorrinolaringol Esp; 2000 May; 51(4):279-87. PubMed ID: 10984949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
